Name: Latest research reports of Laurus Labs Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Laurus Labs Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

1016.7000 0.20 (0.02%)

NSE Dec 04, 2025 09:16 AM

New 52W High in past week

Volume: 21,975

Laurus Labs Ltd.

25 Jan 2024

1016.70

0.02%

Laurus Labs (SELL): Challenges galore cut to SELL

Sell: Laurus Labs Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Fourth straight quarterly miss with upsets on all fronts; Q3 revenue/ EBITDA well short of Bloomberg consensus by 13%/79%

Laurus Labs has gained 75.08% in the last 1 Year